Advertisement
open access
Medical Conferences
Conference Reports
Conference Proceedings
Disease Areas
Medical News
Multimedia
Podcast Channel
Videos
Webinar
About
2024 Medicom Conference Planning
Conference Proceedings
Home
>
Dermatology
>
AAD 2023
AAD 2023
American Academy of Dermatology
17–21 March 2023 New Orleans, USA
Table of Contents
Colophon
Table of Contents
Featured articles
Letter from the Editor
Editor
Prof. Peter van de Kerkhof, Radboud University, the Netherlands
AAD 2023 Highlights Podcast
Presented By
Robert van den Heuvel, Medicom
New Developments in Dermatology
Delgocitinib shows promise as topical therapy for chronic hand eczema
Presented By
Dr Robert Bissonnette, Innovaderm Research, Canada
Vitiligo patients maintain re-pigmentation after ruxolitinib cream withdrawal
Presented By
Prof. John Harris, UMass Chan Medical School, MA, USA
Nemolizumab decreases lesions and itch in prurigo nodularis
Presented By
Prof. Shawn Kwatra , Johns Hopkins University School of Medicine, MD, USA
Lichen planus: a future indication for baricitinib?
Presented By
Ms Angelina Hwang , Mayo Clinic College of Medicine, AZ, USA
Atopic Dermatitis: State of the Art
As-needed ruxolitinib shows successful long-term symptom control in AD
Presented By
Dr Andrew Blauvelt, Oregon Medical Research Center, OR, USA
Dupilumab: a viable option for atopic hand and foot eczema
Presented By
Prof. Eric Simpson, Oregon Health & Science University, OR, USA
Topical roflumilast beneficial in atopic dermatitis
Presented By
Prof. Lawrence Eichenfield, University of California San Diego, CA, USA
IL-22 receptor blocker reduces itch and skin lesions in AD
Presented By
Prof. Diamant Thaçi, University of Lübeck, Germany
Psoriasis: New Developments
Switching to risankizumab successful in IL-17 inhibitor non-responders
Presented By
Prof. Richard Warren, University of Manchester, UK
Novel, selective TYK2 inhibitor shows promise for psoriasis
Presented By
Prof. April Armstrong, Keck School of Medicine of University of California, LA, USA
Hidradenitis Suppurativa: What You Need to Know
Izokibep shows remarkably high grades of clinical response in HS
Presented By
Dr Kim Papp, Probity Medical Research, Canada
Bimekizumab could be the new up-and-comer for HS treatment
Presented By
Prof. Alexa Kimball, Harvard Medical School, MA, USA
Pearls of the Posters
Biologics in psoriasis: can they prevent joint involvement?
Presented By
Ms Kathleen Miao, Keck School of Medicine of USC, CA, USA
JAK inhibitor deuruxolitinib shows encouraging hair re-growth in alopecia areata
Presented By
Dr Maryanne Senna, Lahey Hospital and Medical Center, MA, USA
Biomarkers predicting response of different CSU treatments in children
Presented By
Mr Alex Nguyen, McGill University, Canada